Gene: VCPIP1
Official Full Name: valosin containing protein interacting protein 1provided by HGNC
Gene Summary: Enables cysteine-type deubiquitinase activity. Involved in protein deubiquitination; protein-DNA covalent cross-linking repair; and regulation of protein localization to chromatin. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02731 | VCPIP1 Knockout cell line (HeLa) | Human | VCPIP1 | 1:3~1:6 | Negative | Online Inquiry |
KO02732 | VCPIP1 Knockout cell line (HCT 116) | Human | VCPIP1 | 1:2~1:4 | Negative | Online Inquiry |
KO02733 | VCPIP1 Knockout cell line (HEK293) | Human | VCPIP1 | 1:3~1:6 | Negative | Online Inquiry |
KO02734 | VCPIP1 Knockout cell line (A549) | Human | VCPIP1 | 1:3~1:4 | Negative | Online Inquiry |
VCPIP1 Gene Knockout Cell Lines are genetically engineered cells that have had the VCPIP1 gene effectively disrupted, eliminating its expression. The VCPIP1 gene encodes a protein involved in several critical cellular processes, including the regulation of protein degradation pathways and cellular stress responses. This knockout model is essential for researchers seeking to understand the specific roles of VCPIP1 in cellular homeostasis, signaling pathways, and disease mechanisms.
The key functions of VCPIP1 include its involvement in the deubiquitination processes, which are crucial for modulating proteasomal degradation. By creating a knockout of this gene, researchers can investigate the downstream effects on cellular activity, examine compensatory mechanisms, and elucidate the implications of VCPIP1 in pathologies such as neurodegenerative diseases and cancer. The VCPIP1 Gene Knockout Cell Lines provide a powerful tool for researchers interested in delineating its role in signaling pathways and how its dysregulation may lead to disease.
One of the unique selling points of these cell lines is their specificity and reliability. Unlike other knockout models that may involve promiscuous gene editing techniques, our VCPIP1 Gene Knockout Cell Lines are produced using advanced CRISPR/Cas9 technology, ensuring precise and heritable knockout at the target locus. This reduces off-target effects and improves reproducibility.
Additionally, this product provides researchers the ability to conduct rigorous functional assays to explore treatment options, potential interventions, and gene therapy approaches that target the mechanisms influenced by VCPIP1.
The timely access to high-quality, validated cell lines accelerates research timelines and enhances experimental outcomes. Our company specializes in offering meticulously characterized biological products, backed by a commitment to innovation and scientific excellence. With our extensive expertise in gene editing technology and cell line development, we ensure that our products meet the highest standards, empowering researchers and clinicians to push the boundaries of scientific knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.